A phase 3, multicenter, open-label, randomized study of abarelix versus leuprolide acetate in men with prostate cancer

Autor: McLeod, D., Zinner, N., Tomera, K., Gleason, D., Fotheringham, N., Campion, M., Garnick, M. B.
Zdroj: Urology; 2001, Vol. 58 Issue: 5 p756-761, 6p
Databáze: Supplemental Index